Nasus Pharma (NSRX) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Nasus Pharma (NSRX) is Moderate Underperform.

The composite score behind that read is -0.33, weighing +0.40 of bullish evidence against -0.46 bearish.

Nasus Pharma last closed at $3.77, -1.82% on the session.

Against the IVW growth benchmark the position is -1.66% over the forecast window.

The read is built from 12 underlying insights — 2 bullish and 10 bearish.

Agreement across those insights is 83%.

18 graded predictions for NSRX so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

Nasus Pharma is classified under Health Care / Pharmaceuticals, with a market capitalisation of $44.98M.

StockMap tracks Nasus Pharma as the 113th largest of the 149 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 62 Moderate Underperform, 59 Neutral, 21 Strong Underperform and 7 Moderate Outperform.

On that composite Nasus Pharma ranks 95th of 149 in the group, against a group median of -0.27.